Literature DB >> 19392808

Outcomes for 236 patients from a 2-year early intervention in psychosis service.

M A Turner1, J M Boden, C Smith-Hamel, R T Mulder.   

Abstract

OBJECTIVE: To examine: i) changes in key outcome measures over time in treatment in a representative first-episode psychosis treatment cohort and ii) baseline predictors of service disengagement.
METHOD: Baseline characteristics of 236 patients were examined for associations with outcomes over time using generalized estimating equation models. The data on disengagement were analysed using logistic regression.
RESULTS: After controlling for admission scores, patients showed consistently improved outcomes while in treatment on functional recovery (unemployment, P < 0.01; HoNOS, P < 0.001; the Quality of Life Scale, P < 0.001; GAF, P < 0.05) but not symptomatology (as assessed by the PANSS and substance abuse). The 64 (33%) who disengaged were more likely to be unemployed (P < 0.01) and have higher HoNOS (P < 0.01) and GAF (P < 0.05) scores at baseline.
CONCLUSION: This evaluation has shown significant improvements in psychosocial functioning but not psychopathology during treatment at an Early Intervention for Psychosis Service. Despite attempts to retain patients, there is a high rate of treatment discontinuation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19392808     DOI: 10.1111/j.1600-0447.2009.01386.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  9 in total

1.  Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis.

Authors:  Philippe Conus; Sue Cotton; Benno G Schimmelmann; Patrick D McGorry; Martin Lambert
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-05-05       Impact factor: 4.328

2.  Prediction of Early Symptom Remission in Two Independent Samples of First-Episode Psychosis Patients Using Machine Learning.

Authors:  Rigas F Soldatos; Micah Cearns; Mette Ø Nielsen; Costas Kollias; Lida-Alkisti Xenaki; Pentagiotissa Stefanatou; Irene Ralli; Stefanos Dimitrakopoulos; Alex Hatzimanolis; Ioannis Kosteletos; Ilias I Vlachos; Mirjana Selakovic; Stefania Foteli; Nikolaos Nianiakas; Leonidas Mantonakis; Theoni F Triantafyllou; Aggeliki Ntigridaki; Vanessa Ermiliou; Marina Voulgaraki; Evaggelia Psarra; Mikkel E Sørensen; Kirsten B Bojesen; Karen Tangmose; Anne M Sigvard; Karen S Ambrosen; Toni Meritt; Warda Syeda; Birte Y Glenthøj; Nikolaos Koutsouleris; Christos Pantelis; Bjørn H Ebdrup; Nikos Stefanis
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

Review 3.  The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders.

Authors:  Timothy E Wilens; Diana W Woodward; Je Deuk Ko; Amy F Berger; Colin Burke; Amy M Yule
Journal:  J Child Adolesc Psychopharmacol       Date:  2022-05-04       Impact factor: 3.031

Review 4.  Avoiding the 'twilight zone': recommendations for the transition of services from adolescence to adulthood for young people with ADHD.

Authors:  Susan Young; Clodagh M Murphy; David Coghill
Journal:  BMC Psychiatry       Date:  2011-11-03       Impact factor: 3.630

5.  The Early Youth Engagement in first episode psychosis (EYE-2) study: pragmatic cluster randomised controlled trial of implementation, effectiveness and cost-effectiveness of a team-based motivational engagement intervention to improve engagement.

Authors:  Kathryn Greenwood; Rebecca Webb; Jenny Gu; David Fowler; Richard de Visser; Stephen Bremner; Iga Abramowicz; Nicky Perry; Stuart Clark; Anastacia O'Donnell; Dan Charlton; Rebecca Jarvis; Philippa Garety; Sunil Nandha; Belinda Lennox; Louise Johns; Shanaya Rathod; Peter Phiri; Paul French; Heather Law; Jo Hodgekins; Michelle Painter; Cate Treise; James Plaistow; Francis Irwin; Rose Thompson; Tanya Mackay; Carl R May; Andy Healey; Richard Hooper; Emmanuelle Peters
Journal:  Trials       Date:  2021-04-12       Impact factor: 2.279

Review 6.  Race, ethnicity, and the duration of untreated psychosis: a systematic review.

Authors:  Kelly K Anderson; Nina Flora; Suzanne Archie; Craig Morgan; Kwame McKenzie
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-11-09       Impact factor: 4.328

7.  Treatment adherence with early prescription of long-acting injectable antipsychotics in recent-onset schizophrenia.

Authors:  Annie Viala; Françoise Cornic; Marie-Noëlle Vacheron
Journal:  Schizophr Res Treatment       Date:  2012-04-03

8.  Treatment adherence and social functioning in patients diagnosed with schizophrenia and treated with antipsychotic depot medication.

Authors:  Bianca-Stephanie Popp; Marinela Minodora Manea; Madalina Oana Moraru
Journal:  Clujul Med       Date:  2014-05-30

Review 9.  A systematic review of mental health outcome measures for young people aged 12 to 25 years.

Authors:  Benjamin Kwan; Debra J Rickwood
Journal:  BMC Psychiatry       Date:  2015-11-14       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.